To investigate whether SARM1 mutations that disrupt the enzyme’s autoinhibition are associated with neurogenerative disorders, we sought to identify rare prodegenerative SARM1 missense variants by biochemically analyzing every rare SARM1 variant identified in patients and controls from multiple ALS databases. Here, SARM1 is linked to amyotrophic lateral sclerosis.